MyFinsight
Home
Compare
About
Recent SEC Filings
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Cash Flow Overview
Change in Cash
$856K
Free Cash flow
$895K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Accounts receivable
Amortization of right-of-use ass...
Accounts payable
Others
Negative Cash Flow Breakdown
Net (loss) income
Operating lease obligations
Purchase of property and equipme...
Others
Subscribe for Financial Insights
Page 1
Annual
123
Page 1
Cash Flow
2026-06-30
2025-06-30
Net (loss) income
-2,842
808
Amortization of right-of-use assets
1,095
951
Depreciation and amortization
293
318
Deferred income taxes, net
258
1,264
Compensation expense on employee stock options
192
185
Allowance for (charge offs of) uncollectible accounts receivable, net
0
19
Loss on disposal of fixed assets
6
-4
Impairment charge on equipment
30
28
Other, net
12
-10
Accounts receivable
-2,096
781
Inventories
-220
-1,882
Other assets
89
92
Operating lease obligations
-1,034
-945
Accounts payable
925
-211
Accrued expenses and other current liabilities
91
-1,355
Net cash provided by operating activities
1,241
2,065
Purchase of property and equipment
346
191
Purchase portion of right of use asset - financed
0
14
Proceeds from sale of property and equipment
6
-
Net cash used in investing activities
-340
-205
Proceeds from exercises of stock options
0
86
Repayments under financed lease obligations
45
8
Net cash (used in) provided by financing activities
-45
78
Net increase in cash
856
1,938
Cash at beginning of fiscal year
3,615
1,677
Cash at end of fiscal year
4,471
3,615
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS).
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
INBP Cash Flow Sankey Diagram
Sankey diagram visualizing INBP cash flow for the period
Accounts receivable
-$2,096K
(-368.37%↓ Y/Y)
Amortization of right-of-use
assets
$1,095K
(15.14%↑ Y/Y)
Accounts payable
$925K
(538.39%↑ Y/Y)
Depreciation and
amortization
$293K
(-7.86%↓ Y/Y)
Deferred income taxes,
net
$258K
(-79.59%↓ Y/Y)
Inventories
-$220K
(88.31%↑ Y/Y)
Compensation expense on
employee stock options
$192K
(3.78%↑ Y/Y)
Accrued expenses and
other current...
$91K
(106.72%↑ Y/Y)
Impairment charge on
equipment
$30K
(7.14%↑ Y/Y)
Other, net
$12K
(220.00%↑ Y/Y)
Net cash provided by
operating activities
$1,241K
(-39.90%↓ Y/Y)
Canceled cashflow
$3,971K
Net increase in cash
$856K
(-55.83%↓ Y/Y)
Canceled cashflow
$385K
Net (loss) income
-$2,842K
(-451.73%↓ Y/Y)
Operating lease
obligations
-$1,034K
(-9.42%↓ Y/Y)
Other assets
$89K
(-3.26%↓ Y/Y)
Loss on disposal of
fixed assets
$6K
(250.00%↑ Y/Y)
Proceeds from sale of
property and equipment
$6K
Net cash used in
investing activities
-$340K
(-65.85%↓ Y/Y)
Net cash (used in)
provided by financing...
-$45K
(-157.69%↓ Y/Y)
Canceled cashflow
$6K
Purchase of property and
equipment
$346K
(81.15%↑ Y/Y)
Repayments under financed
lease obligations
$45K
(462.50%↑ Y/Y)
Buy us a coffee
INTEGRATED BIOPHARMA INC (INBP)
INTEGRATED BIOPHARMA INC (INBP)